These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 31707924)
1. Bicalutamide-associated hallucinations in a metastatic prostate cancer patient: A case report. Turkkan G; Dogan C; Tek B J Oncol Pharm Pract; 2020 Jun; 26(4):1029-1031. PubMed ID: 31707924 [TBL] [Abstract][Full Text] [Related]
2. Hot flashes during androgen deprivation therapy with luteinizing hormone-releasing hormone agonist combined with steroidal or nonsteroidal antiandrogen for prostate cancer. Sakai H; Igawa T; Tsurusaki T; Yura M; Kusaba Y; Hayashi M; Iwasaki S; Hakariya H; Hara T; Kanetake H Urology; 2009 Mar; 73(3):635-40. PubMed ID: 19038426 [TBL] [Abstract][Full Text] [Related]
3. Atypical onset of bicalutamide-induced liver injury. Yun GY; Kim SH; Kim SW; Joo JS; Kim JS; Lee ES; Lee BS; Kang SH; Moon HS; Sung JK; Lee HY; Kim KH World J Gastroenterol; 2016 Apr; 22(15):4062-5. PubMed ID: 27099451 [TBL] [Abstract][Full Text] [Related]
4. Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition. Smith MR; Goode M; Zietman AL; McGovern FJ; Lee H; Finkelstein JS J Clin Oncol; 2004 Jul; 22(13):2546-53. PubMed ID: 15226323 [TBL] [Abstract][Full Text] [Related]
6. An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients. Bedognetti D; Rubagotti A; Conti G; Francesca F; De Cobelli O; Canclini L; Gallucci M; Aragona F; Di Tonno P; Cortellini P; Martorana G; Lapini A; Boccardo F Eur Urol; 2010 Feb; 57(2):238-45. PubMed ID: 19481335 [TBL] [Abstract][Full Text] [Related]
7. Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years. Iversen P; McLeod DG; See WA; Morris T; Armstrong J; Wirth MP; BJU Int; 2010 Apr; 105(8):1074-81. PubMed ID: 22129214 [TBL] [Abstract][Full Text] [Related]
8. Bicalutamide (Casodex) in the treatment of prostate cancer: history of clinical development. Kolvenbag GJ; Blackledge GR; Gotting-Smith K Prostate; 1998 Jan; 34(1):61-72. PubMed ID: 9428389 [TBL] [Abstract][Full Text] [Related]
9. Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database. Beebe-Dimmer JL; Ruterbusch JJ; Bylsma LC; Gillezeau C; Fryzek J; Schultz NM; Flanders SC; Barlev A; Heath E; Quek RGW Adv Ther; 2018 Sep; 35(9):1438-1451. PubMed ID: 29946798 [TBL] [Abstract][Full Text] [Related]
10. [DRUG-INDUCED INTERSTITIAL LUNG DISEASE DURING COMBINED ANDROGEN BLOCKADE WITH BICALUTAMIDE AND LEUPRORELIN ACETATE FOR PROSTATE CANCER]. Maeda K; Osafune T; Masuda Y; Takeda T; Kageyama S; Narita M; Kawauchi A Nihon Hinyokika Gakkai Zasshi; 2019; 110(1):36-40. PubMed ID: 31956217 [TBL] [Abstract][Full Text] [Related]
11. [Effect of change to flutamide for prostate cancer patient who developed breast pain during bicalutamide treatment (BIP-F study)]. Kitamura Y; Okuno H; Sakura Y; Manabe Y; Masuda N; Ito H; Mishina M; Taoka R; Terai A; Sugimoto M; Kakehi Y Hinyokika Kiyo; 2014 Jan; 60(1):17-23. PubMed ID: 24594768 [TBL] [Abstract][Full Text] [Related]
12. Drug-induced photosensitivity to bicalutamide - case report and review of the literature. Lee K; Oda Y; Sakaguchi M; Yamamoto A; Nishigori C Photodermatol Photoimmunol Photomed; 2016 May; 32(3):161-4. PubMed ID: 26663090 [No Abstract] [Full Text] [Related]
13. [Management of gynecomastia induced by bicalutamide]. Haddad E Ann Urol (Paris); 2006 Dec; 40 Suppl 2():S49-52. PubMed ID: 17361921 [TBL] [Abstract][Full Text] [Related]
14. Cross-sectional study of bone turnover during bicalutamide monotherapy for prostate cancer. Smith MR; Fallon MA; Goode MJ Urology; 2003 Jan; 61(1):127-31. PubMed ID: 12559282 [TBL] [Abstract][Full Text] [Related]
15. Long-term effectiveness of luteinizing hormone-releasing hormone agonist or antiandrogen monotherapy in elderly men with localized prostate cancer (T1-2): a retrospective study. Raina R; Pahalajani G; Agarwal A; Zippe C Asian J Androl; 2007 Mar; 9(2):253-8. PubMed ID: 17334592 [TBL] [Abstract][Full Text] [Related]